Rallybio Corporation
RLYB
$0.626
$0.0325.39%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 40.24% | 50.40% | 45.44% | 37.60% | 12.85% |
Total Depreciation and Amortization | -23.53% | -20.00% | -16.67% | -13.51% | -10.53% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -11.98% | 0.98% | -17.09% | -9.93% | -4.29% |
Change in Net Operating Assets | -111.85% | -334.08% | -115.27% | -521.88% | 21.23% |
Cash from Operations | 19.57% | 33.98% | 15.31% | 17.76% | 22.16% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 16.91% | 7.96% | -109.30% | 623.29% | -58.22% |
Cash from Investing | 16.91% | 7.96% | -109.30% | 623.29% | -58.22% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -99.82% | -- | -75.34% | -- | 2,507.18% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | 100.00% | -- | -25,800.00% |
Cash from Financing | -99.81% | -- | -75.00% | -- | 2,372.38% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -102.81% | 116.87% | -313.96% | 164.54% | 62.21% |